Vac Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 38 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 15.00%
- Net Worth -1.32%
- Total Assets -7.62%
About Vac Pharmaceuticals
Vac Pharmaceuticals Pvt. Ltd. (VPPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 July 1986 and has a history of 38 years and six months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jayant Vaknalli and Sunila Vaknalli serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230MH1986PTC040497
- Company No.
040497
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jul 1986
- Date of AGM
16 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Vac Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayant Vaknalli  | Director | 28-Jul-1986 | Current |
| Sunila Vaknalli | Director | 20-Feb-2009 | Current |
Financial Performance of Vac Pharmaceuticals.
Vac Pharmaceuticals Pvt. Ltd., for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 15% increase in profit. The company's net worth dipped by a decrease of 1.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Vac Pharmaceuticals?
In 2017, Vac Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medisynth Chemicals Pvt LtdJayant Vaknalli and Sunila Vaknalli are mutual person
- Medisynth Naturals Private Limited
Jayant Vaknalli and Sunila Vaknalli are mutual person
New Era Homoeopathic Pharmacy LlpJayant Vaknalli and Sunila Vaknalli are mutual person
- Beck And Koll Laboratories Private Limited
Jayant Vaknalli and Sunila Vaknalli are mutual person
- Vcnally Sales Private Limited
Jayant Vaknalli and Sunila Vaknalli are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vac Pharmaceuticals?
Unlock and access historical data on people associated with Vac Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vac Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vac Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
